Physician profile
Gilbert S Chandler
NPI 1003807272
$5,887.01
in general payments reported to CMS, 2019-2025
15 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $49.67 · 2021: $713 · 2022: $2,654 · 2023: $1,370 · 2024: $304 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,214 · Travel and Lodging: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,214.12 |
| Travel and Lodging | $773.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $2,435.91 | 2022-2025 | |
| Relievant Medsystems, INC. | $1,942.58 | 2021-2023 | Intracept |
| Boston Scientific Corporation | $673.26 | 2019-2025 | Intracept |
| Nevro Corp. | $240.05 | 2019-2023 | Senza |
| Bioventus LLC | $120.44 | 2021 | |
| Medtronic USA, INC. | $115.71 | 2019-2020 | |
| Si-Bone, INC. | $101.20 | 2019 | |
| Vertiflex, INC. | $80.61 | 2019 | |
| Avanos Medical | $43.89 | 2022 | |
| Abbvie INC. | $28.96 | 2025 | |
| Stryker Corporation | $25.62 | 2019 | |
| Medtronic, INC. | $23.67 | 2022 | |
| Spr Therapeutics, INC | $22.55 | 2025 | Sprint Pns System |
| Abbott Laboratories | $19.94 | 2020 | |
| Pfizer INC. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Chandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.